Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

Open access

Abstract

Peroxisome proliferator-activated receptor delta (PPARδ), a member of the nuclear receptor family, is emerging as a key metabolic regulator with pleiotropic actions on various tissues including fat, skeletal muscle, and liver. Here we show that the PPARδ agonist KD3010, but not the well-validated GW501516, dramatically ameliorates liver injury induced by carbon tetrachloride (CCl(4)) injections. Deposition of extracellular matrix proteins was lower in the KD3010-treated group than in the vehicle- or GW501516-treated group. Interestingly, profibrogenic connective tissue growth factor was induced significantly by GW501516, but not by KD3010, following CCl(4) treatment. The hepatoprotective and antifibrotic effect of KD3010 was confirmed in a model of cholestasis-induced liver injury and fibrosis using bile duct ligation for 3 wk. Primary hepatocytes treated with KD3010 but not GW501516 were protected from starvation or CCl(4)-induced cell death, in part because of reduced reactive oxygen species production. In conclusion, our data demonstrate that an orally active PPARδ agonist has hepatoprotective and antifibrotic effects in animal models of liver fibrosis, suggesting a possible mechanistic and therapeutic approach in treating patients with chronic liver diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1202464109

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 2

  1. B Schnabl, D Scholten, DA Brenner, What is the potential role of antifibrotic agents for the treatment of liver disease? Nat Clin Pract Gastroenterol Hepatol 5, 496–497 (2008). · DOI
  2. M Downes, et al., A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell 11, 1079–1092 (2003). · DOI · Paper page

Cited by

See all 159

Metadata

Authors
Iwaisako, K., Haimerl, M., Paik, Y.-H., Taura, K., Kodama, Y., Sirlin, C., Yu, E., Yu, R. T., Downes, M., Evans, R. M., Brenner, D. A., & Schnabl, B.
Affiliations
  • University of California San Diego (US)
  • Departments of aMedicine and
  • Samsung Medical Center (KR)
  • Salk Institute for Biological Studies (US)
Venue
Proceedings of the National Academy of Sciences
Published
2012-04-25
Volume
109
Issue
21
Pages
E1369-76
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2105900654
Cited by
157
References
24
Citations by year
2026: 6 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 6 · 2021: 10 · 2020: 18 · 2019: 10 · 2018: 13 · 2017: 14 · 2016: 13 · 2015: 11 · 2014: 9 · 2013: 16 · 2012: 3
FWCI
5.01
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • Japan Society for the Promotion of Science (22590728, 23659647, 23390322)
  • National Institute on Alcohol Abuse and Alcoholism (R01AA020703)
  • National Cancer Institute (P30CA014195)
  • National Institute of General Medical Sciences (R01GM041804)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R24DK080506, R37DK057978, DK 080506, R01DK057978, R01DK072237, R24DK090962, K08DK081830)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD000850)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
PPARδ agonist, GW501516, liver fibrosis, hepatoprotection, carbon tetrachloride-induced liver injury, bile duct ligation, cholestasis, connective tissue growth factor, extracellular matrix deposition, reactive oxygen species, hepatocyte death, chronic liver disease
MeSH terms
Animals, Carbon Tetrachloride, Cells, Cultured, Disease Models, Animal, Kupffer Cells, Liver Cirrhosis, Male, Mice, Inbred C57BL, Piperazines, Sulfonamides, Thiazoles, Hepatocytes, PPAR delta, Mice, Hepatic Stellate Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist. https://app.cochat.ai/papers/10.1073/pnas.1202464109
The paper
Iwaisako, K., Haimerl, M., Paik, Y.-H., Taura, K., Kodama, Y., Sirlin, C., Yu, E., Yu, R. T., Downes, M., Evans, R. M., Brenner, D. A., & Schnabl, B. (2012). Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1202464109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.